Evidence map›Paper›PMID 38842361›Full record

ArticleMicrobiology spectrum2024

Antibacterial efficacy and membrane mechanism of action of the

Tanya Decker, Marina Rautenbach, Sehaam Khan, Wesaal Khan

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Potential of Fermented Food-DerivedInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tanya DeckerWater Health Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, Johannesburg, Gauteng, South Africa.ORCID 0000-0001-5701-0590
Marina RautenbachBioPep Peptide Group, Department of Biochemistry, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.
Sehaam KhanWater Health Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, Johannesburg, Gauteng, South Africa.
Wesaal KhanDepartment of Microbiology, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.ORCID 0000-0003-1559-9485

Funding

National Research Foundation (NRF) 113849
6 · The paper itself

Abstract

The study aimed to investigate the antibacterial activity, cytotoxicity, and mechanism of action of the non-ionic, cyclic lipopeptide, serrawettin W2-FL10 against IMPORTANCE: Antimicrobial resistance is a major public health concern, urgently requiring antibacterial compounds exhibiting low adverse health effects. In this study, a novel antibacterial lipopeptide analog is described, serrawettin W2-FL10 (derived from

Indexed as

Anti-Bacterial AgentsCell MembraneLipopeptidesMicrobial Sensitivity TestsStaphylococcus aureusAnimalsCell Membrane PermeabilityGram-Negative BacteriaGram-Positive BacteriaTeichoic AcidsAnti-Bacterial AgentsLipopeptidesTeichoic Acidsantibacterialcytoplasmic membranelipopeptidemode of actionserrawettin W2

Identifiers

PMID38842361
PMCPMC11218446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.